Pharming Group NV Stock Price, News & Analysis (OTCMKTS:PHGUF)

$1.50 0.07 (4.90 %)
(As of 11/17/2017 02:35 PM ET)
Previous Close$1.50
Today's Range$1.50 - $1.50
52-Week Range$0.25 - $1.56
Volume5,000 shs
Average Volume52,877 shs
Market Capitalization$765.56 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Pharming Group NV (OTCMKTS:PHGUF)

Pharming Group NV logoPharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company’s products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming’s technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company’s commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.


Industry, Sector and Symbol:
  • Industry: N/A
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: OTCMKTS:PHGUF
  • Previous Symbol: OTC:PHGUF
  • CUSIP: N/A
  • Web: www.pharming.com
Debt:
  • Debt-to-Equity Ratio: 11.72%
  • Current Ratio: 1.77%
  • Quick Ratio: 1.27%
Sales & Book Value:
  • Annual Sales: $17.57 million
  • Price / Sales: 45.71
  • Book Value: $0.07 per share
  • Price / Book: 21.43
Profitability:
  • Net Income: ($19,400,000.00)
  • Net Margins: -69.48%
  • Return on Equity: -215.48%
  • Return on Assets: -35.22%
Misc:
  • Employees: 94
  • Outstanding Shares: 535,360,000
 
Frequently Asked Questions for Pharming Group NV (OTCMKTS:PHGUF)

What is Pharming Group NV's stock symbol?

Pharming Group NV trades on the OTCMKTS under the ticker symbol "PHGUF."

How were Pharming Group NV's earnings last quarter?

Pharming Group NV (OTCMKTS:PHGUF) issued its earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.04 by $0.01. Pharming Group NV had a negative net margin of 69.48% and a negative return on equity of 215.48%. View Pharming Group NV's Earnings History.

When will Pharming Group NV make its next earnings announcement?

Pharming Group NV is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for Pharming Group NV.

Who are some of Pharming Group NV's key competitors?

Who are Pharming Group NV's key executives?

Pharming Group NV's management team includes the folowing people:

  • Paul Jai Sekhri, Chairman of the Board of Supervisory Directors (Age 59)
  • Sijmen de Vries, Member of the Management Board, Chief Executive Officer (Age 58)
  • Juergen H. L. Ernst, Vice Chairman of the Board of Supervisory Directors (Age 78)
  • Robin Wright, Chief Financial Officer, Member of the Management Board (Age 53)
  • Bruno M. Giannetti, Member of the Management Board, Chief Operations Officer (Age 65)
  • Anne-Marie de Groot, Senior Vice President Organizational Development, Member of the Management Board
  • Jaap Blaak, Member of the Board of Supervisory Directors (Age 76)
  • Aad de Winter, Member of the Board of Supervisory Directors (Age 64)
  • Jan H. Egberts M.D., Member of the Board of Supervisory Directors (Age 58)
  • Jonh Barrie Ward Ph.D., Member of the Board of Supervisory Directors (Age 76)

How do I buy Pharming Group NV stock?

Shares of Pharming Group NV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pharming Group NV's stock price today?

One share of Pharming Group NV stock can currently be purchased for approximately $1.50.

How big of a company is Pharming Group NV?

Pharming Group NV has a market capitalization of $765.56 million and generates $17.57 million in revenue each year. Pharming Group NV employs 94 workers across the globe.

How can I contact Pharming Group NV?

Pharming Group NV's mailing address is Darwinweg 24, LEIDEN, 2333 CR, Netherlands. The biotechnology company can be reached via phone at +31-71-5247400 or via email at [email protected]


MarketBeat Community Rating for Pharming Group NV (OTCMKTS PHGUF)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  52 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  131
MarketBeat's community ratings are surveys of what our community members think about Pharming Group NV and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Ratings for Pharming Group NV (OTCMKTS:PHGUF) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Analysts' Consensus Price Target: N/A
Consensus Price Target History for Pharming Group NV (OTCMKTS:PHGUF)
Price Target History for Pharming Group NV (OTCMKTS:PHGUF)
Analysts' Ratings History for Pharming Group NV (OTCMKTS:PHGUF)
Show:
DateFirmActionRatingPrice TargetDetails
10/26/2017HC WainwrightReiterated RatingBuyView Rating Details
1/24/2017Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 11/17/2015 forward)

Earnings

Earnings History for Pharming Group NV (OTCMKTS:PHGUF)
Earnings by Quarter for Pharming Group NV (OTCMKTS:PHGUF)
Earnings History by Quarter for Pharming Group NV (OTCMKTS PHGUF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2018        
3/5/2015$0.04$0.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pharming Group NV (OTCMKTS:PHGUF)
Current Year EPS Consensus Estimate: $-0.07 EPS
Next Year EPS Consensus Estimate: $0.07 EPS

Dividends

Dividend History for Pharming Group NV (OTCMKTS:PHGUF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pharming Group NV (OTCMKTS PHGUF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Pharming Group NV (OTCMKTS:PHGUF)
Latest Headlines for Pharming Group NV (OTCMKTS PHGUF)
Source:
No headlines for this company have been tracked by MarketBeat.com

Social Media

Financials

Financials are not available for this stock.

Chart

Pharming Group NV (OTCMKTS PHGUF) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.